We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$300M
AUM Growth
+$37.9M
Cap. Flow
+$28.4M
Cap. Flow %
9.48%
Top 10 Hldgs %
73.7%
Holding
63
New
9
Increased
29
Reduced
10
Closed
8

Sector Composition

Rank Sector Weight
1 Miscellaneous 97.78%
2 Healthcare 1.77%
3 Consumer Staples 0.33%
4 Materials 0.06%
5 Communication Services 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
26
Biogen
BIIB
$32.3B
$1.66M 0.55%
5,416
AAXJ icon
27
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$1.61M 0.54%
27,171
-1,635
-6% -$93.8K
XLU icon
28
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$1.45M 0.48%
69,900
+5,904
+9% +$116K
XLB icon
29
State Street Materials Select Sector SPDR ETF
XLB
$8.81B
$1.45M 0.48%
61,240
+3,680
+6% +$84.6K
DBC icon
30
Invesco DB Commodity Index Tracking Fund
DBC
$1.82B
$1.22M 0.41%
46,528
-474
-1% -$12.1K
RLY icon
31
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$1.19M 0.4%
40,228
+311
+0.8% +$8.99K
SJNK icon
32
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$1.14M 0.38%
36,937
+395
+1% +$12.2K
CMBS icon
33
iShares CMBS ETF
CMBS
$472M
$1.11M 0.37%
21,785
EBND icon
34
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$1.1M 0.37%
36,972
+158
+0.4% +$4.58K
ZVO
35
DELISTED
Zovio Inc. Common Stock
ZVO
$994K 0.33%
+66,740
New +$1.15M
SRLN icon
36
State Street Blackstone Senior Loan ETF
SRLN
$5.48B
$728K 0.24%
14,552
+83
+0.6% +$4.16K
RGLS
37
DELISTED
Regulus Therapeutics
RGLS
$726K 0.24%
671
+218
+48% +$242K
DSI icon
38
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$722K 0.24%
20,550
VV icon
39
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$688K 0.23%
+8,000
New +$676K
BOND icon
40
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
$597K 0.2%
5,595
+1,985
+55% +$211K
NBIX icon
41
Neurocrine Biosciences
NBIX
$15.7B
$441K 0.15%
27,365
+5,500
+25% +$94.1K
LDUR icon
42
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.34B
$318K 0.11%
+3,165
New +$318K
SZYM
43
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$290K 0.1%
25,000
+4,500
+22% +$52.9K
DLN icon
44
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$283K 0.09%
8,354
VNQ icon
45
Vanguard Real Estate ETF
VNQ
$38.6B
$254K 0.08%
3,601
-209
-5% -$14.3K
ILMN icon
46
Illumina
ILMN
$32.6B
$237K 0.08%
+1,637
New +$241K
SQNM
47
DELISTED
SEQUENOM INC NEW
SQNM
$221K 0.07%
90,000
TLRA
48
DELISTED
Telaria, Inc.
TLRA
$176K 0.06%
+42,828
New +$196K
IMUC
49
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$85K 0.03%
1,750
KGC icon
50
Kinross Gold
KGC
$37.1B
$81K 0.03%
+19,500
New +$93.5K

Similar funds

Callan Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Callan Capital held 63 positions worth $300M, up 15% from $262M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Callan Capital deployed $28.4M of net new capital in Q1 2014, opening 9 new positions and adding to 29 existing holdings. Its largest new stake was Zovio Inc. Common Stock: 66,740 shares worth $994K.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 98% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Japan Hedged Equity Fund, an estimated $284K trimmed.

  • Callan Capital's largest Q1 2014 buy was Zovio Inc. Common Stock: 66,740 shares worth $994K.
  • Callan Capital added most to RECEPTOS INC COM STK (DE) in Q1 2014, an estimated $4.18M increase.
  • Callan Capital's biggest Q1 2014 reduction was WisdomTree Japan Hedged Equity Fund, cutting an estimated $284K.
  • Callan Capital fully exited Wheaton Precious Metals in Q1 2014, selling an estimated $212K.
  • Callan Capital's ten largest holdings make up 74% of its $300M portfolio in Q1 2014.
  • Callan Capital opened 9 new positions and closed 8 in Q1 2014.
  • Callan Capital's portfolio value rose 15% quarter-over-quarter to $300M.

Based on Callan Capital's 13F filing for Q1 2014, filed 8 May 2014.